Zhanhai Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhanhai Yin has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Meiguang Xu
Department of Orthopaedics The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 China
5 shared publicationsBaojun Chen
Department of Surgery of Spine and Spinal Cord Henan Provincial People's Hospital Zhengzhou 450003 China
4 shared publicationsLang Bai
Department of Orthopedics, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Shaanxi, 710061, P. R. China
4 shared publicationsQian Han
Department of Orthopedics, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Shaanxi, 710061, P. R. China
4 shared publications- Baolin Guo
Xi’an Jiaotong University
3 shared publications Jing Zhang
3 shared publications
Latest Publications
- 1 October 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (12)
Rethinking Obesity-Driven Urgency in Rotator Cuff Repair: Response
- 1 October 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (12)
Rethinking Obesity-Driven Urgency in Rotator Cuff Repair: Response
- Open Access
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Rehabilitation Sciences
- Vol. 6, 1731044
The effects of extracorporeal shockwave therapy on bone mineral density and microarchitecture in animal models of osteoporosis: a systematic review and meta-analysis
Objective: This systematic review and meta-analysis aimed to provide the first comprehensive, quantitative assessment of the efficacy of Extracorporeal Shockwave Therapy (ESWT) in improving bone mineral density (BMD) and key trabecular microarchitectural parameters (BV/TV, Tb.Sp, Tb.N, Tb.Th) in animal models of osteoporosis (OP). Methods: We systematically searched six electronic databases for relevant animal randomized controlled trials (RCTs). Data extraction and quality assessment were performed on the seven studies that met the inclusion criteria. All statistical analyses were conducted using RevMan 5.4. Results: The meta-analysis revealed that ESWT significantly improved all assessed parameters: (1) a significant increase in BMD [SMD = 2.12, 95% CI (1.50, 2.73), P < 0.00001] with low heterogeneity ( I 2 = 0%); (2) a significant increase in bone volume fraction [BV/TV, SMD = 2.26, 95% CI (0.20, 4.32), P = 0.03] with high heterogeneity ( I 2 = 76%); (3) a significant decrease in trabecular separation [Tb.Sp, SMD = −1.39, 95% CI (−2.64, −0.14), P = 0.03] with moderate heterogeneity ( I 2 = 63%); (4) a significant increase in trabecular number [Tb.N, SMD = 3.51, 95% CI (1.93, 5.10), P < 0.0001] with moderate heterogeneity ( I 2 = 62%); and (5) a significant increase in trabecular thickness [Tb.Th, MD = 0.09, 95% CI (0.04, 0.13), P = 0.0005] with low heterogeneity ( I 2 = 20%). Although initial heterogeneity for BV/TV, Tb.Sp, and Tb.N was high, sensitivity analysis identified the sources, and their removal resulted in more stable effect estimates. Conclusion: As the first quantitative synthesis in this field, this study provides preclinical evidence suggesting that ESWT is associated with improvements in bone density and optimizes bone microarchitecture. These findings establish a critical data foundation for ESWT as a potential non-invasive therapy for OP. However, it is important to note that the certainty of these findings is tempered by several factors, including the observed high heterogeneity for BV/TV, Tb.Sp, and Tb.N, the small total sample sizes across outcomes, and the potential for publication bias. The results are further constrained by exclusive reliance on animal models and a limited number of included studies. Future clinical research is required to validate these findings and further elucidate the underlying mechanisms.
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Rehabilitation Sciences
- Vol. 6, 1731044
Open AccessThe effects of extracorporeal shockwave therapy on bone mineral density and microarchitecture in animal models of osteoporosis: a systematic review and meta-analysis
Objective: This systematic review and meta-analysis aimed to provide the first comprehensive, quantitative assessment of the efficacy of Extracorporeal Shockwave Therapy (ESWT) in improving bone mineral density (BMD) and key trabecular microarchitectural parameters (BV/TV, Tb.Sp, Tb.N, Tb.Th) in animal models of osteoporosis (OP). Methods: We systematically searched six electronic databases for relevant animal randomized controlled trials (RCTs). Data extraction and quality assessment were performed on the seven studies that met the inclusion criteria. All statistical analyses were conducted using RevMan 5.4. Results: The meta-analysis revealed that ESWT significantly improved all assessed parameters: (1) a significant increase in BMD [SMD = 2.12, 95% CI (1.50, 2.73), P < 0.00001] with low heterogeneity ( I 2 = 0%); (2) a significant increase in bone volume fraction [BV/TV, SMD = 2.26, 95% CI (0.20, 4.32), P = 0.03] with high heterogeneity ( I 2 = 76%); (3) a significant decrease in trabecular separation [Tb.Sp, SMD = −1.39, 95% CI (−2.64, −0.14), P = 0.03] with moderate heterogeneity ( I 2 = 63%); (4) a significant increase in trabecular number [Tb.N, SMD = 3.51, 95% CI (1.93, 5.10), P < 0.0001] with moderate heterogeneity ( I 2 = 62%); and (5) a significant increase in trabecular thickness [Tb.Th, MD = 0.09, 95% CI (0.04, 0.13), P = 0.0005] with low heterogeneity ( I 2 = 20%). Although initial heterogeneity for BV/TV, Tb.Sp, and Tb.N was high, sensitivity analysis identified the sources, and their removal resulted in more stable effect estimates. Conclusion: As the first quantitative synthesis in this field, this study provides preclinical evidence suggesting that ESWT is associated with improvements in bone density and optimizes bone microarchitecture. These findings establish a critical data foundation for ESWT as a potential non-invasive therapy for OP. However, it is important to note that the certainty of these findings is tempered by several factors, including the observed high heterogeneity for BV/TV, Tb.Sp, and Tb.N, the small total sample sizes across outcomes, and the potential for publication bias. The results are further constrained by exclusive reliance on animal models and a limited number of included studies. Future clinical research is required to validate these findings and further elucidate the underlying mechanisms.
Electrohydrodynamic‐Printed Dual‐Triphase Microfibrous Scaffolds Reshaping the Lipidomic Profile for Enthesis Healing in a Rat Rotator Cuff Repair Model
Rotator cuff injuries often result in chronic pain and functional limitations due to retears and scar formation at the enthesis. This study assess the efficacy of electrohydrodynamic‐printed microfibrous dual‐triphase scaffolds (DTSs), designed to optimize enthesis repair. These scaffolds, composed of polycaprolactone enhanced with nanohydroxyapatite, nano‐magnesium‐oxide, and kartogenin demonstrate significant biological advantages. In vitro, the scaffolds support over 95% stem cell viability and promote enhanced expression of critical markers such as tenomodulin (TNMD), sex‐determining region Y‐Box transcription factor 9 (SOX‐9), and runt‐related transcription factor 2 (RUNX‐2). Enhanced expressions of tendon markers tenomodulin and scleraxis (SCX) are noted, alongside significant upregulation of chondrocyte and osteoblast markers. In vivo, these scaffolds significantly improve the biomechanical properties of the repaired enthesis, with a maximum failure load of 27.0 ± 4.2 N and ultimate stress of 5.5 ± 1.0 MPa at 6 weeks postimplantation. Lipidomic analysis indicates substantial regulation of phospholipids such as phosphatidylcholine and phosphatidylserine, highlighting the scaffold's capacity to modulate biochemical pathways critical for tissue repair and regeneration. This study underscores the potential of DTS to improve clinical outcomes in rotator cuff injury treatment by enhancing cellular differentiation, biomechanical properties, and biochemical environment, setting a foundation for personalized treatment strategies in tendon–bone repair.
Electrohydrodynamic‐Printed Dual‐Triphase Microfibrous Scaffolds Reshaping the Lipidomic Profile for Enthesis Healing in a Rat Rotator Cuff Repair Model
Rotator cuff injuries often result in chronic pain and functional limitations due to retears and scar formation at the enthesis. This study assess the efficacy of electrohydrodynamic‐printed microfibrous dual‐triphase scaffolds (DTSs), designed to optimize enthesis repair. These scaffolds, composed of polycaprolactone enhanced with nanohydroxyapatite, nano‐magnesium‐oxide, and kartogenin demonstrate significant biological advantages. In vitro, the scaffolds support over 95% stem cell viability and promote enhanced expression of critical markers such as tenomodulin (TNMD), sex‐determining region Y‐Box transcription factor 9 (SOX‐9), and runt‐related transcription factor 2 (RUNX‐2). Enhanced expressions of tendon markers tenomodulin and scleraxis (SCX) are noted, alongside significant upregulation of chondrocyte and osteoblast markers. In vivo, these scaffolds significantly improve the biomechanical properties of the repaired enthesis, with a maximum failure load of 27.0 ± 4.2 N and ultimate stress of 5.5 ± 1.0 MPa at 6 weeks postimplantation. Lipidomic analysis indicates substantial regulation of phospholipids such as phosphatidylcholine and phosphatidylserine, highlighting the scaffold's capacity to modulate biochemical pathways critical for tissue repair and regeneration. This study underscores the potential of DTS to improve clinical outcomes in rotator cuff injury treatment by enhancing cellular differentiation, biomechanical properties, and biochemical environment, setting a foundation for personalized treatment strategies in tendon–bone repair.
- 15 March 2024
- Vol. 38 (3) , 380-386
镁及镁合金植入物在运动医学中的应用研究进展
对镁及镁合金植入物在运动相关损伤修复重建中的应用研究进展进行综述。 广泛查阅近年来国内外相关研究文献,对镁及镁合金材料特性和其用于不同部位运动损伤修复重建的研究进展进行总结。 镁与镁合金材料在机械性能、生物安全性和促腱-骨界面愈合能力方面具有优势,目前有关镁与镁合金植入物修复重建运动相关损伤的临床前研究也取得了较好结果,但是其成功临床转化还需解决机械强度和降解行为问题,合金化和表面处理是可行的解决方案。 镁及镁合金植入物应用于运动损伤修复重建有望实现临床转化,后续应优化其机械强度和降解行为,开展更大规模的生物安全性测试和开发新型含镁植入物是未来研究方向。
- 15 March 2024
- Vol. 38 (3) , 380-386
镁及镁合金植入物在运动医学中的应用研究进展
对镁及镁合金植入物在运动相关损伤修复重建中的应用研究进展进行综述。 广泛查阅近年来国内外相关研究文献,对镁及镁合金材料特性和其用于不同部位运动损伤修复重建的研究进展进行总结。 镁与镁合金材料在机械性能、生物安全性和促腱-骨界面愈合能力方面具有优势,目前有关镁与镁合金植入物修复重建运动相关损伤的临床前研究也取得了较好结果,但是其成功临床转化还需解决机械强度和降解行为问题,合金化和表面处理是可行的解决方案。 镁及镁合金植入物应用于运动损伤修复重建有望实现临床转化,后续应优化其机械强度和降解行为,开展更大规模的生物安全性测试和开发新型含镁植入物是未来研究方向。
- Open Access
- 31 July 2023
- Published by Elsevier in Journal of Functional Foods
- Vol. 107
Epigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis
- 31 July 2023
- Published by Elsevier in Journal of Functional Foods
- Vol. 107
Open AccessEpigallocatechin gallate (EGCG) can epigenetically regulate the receptor of advanced glycation end products (RAGE) to ameliorate Osteoarthritis
- Open Access
- 14 February 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1062229
Advanced glycation end products regulate the receptor of AGEs epigenetically
Advanced glycation end-products (AGEs) can boost their receptor of AGE (RAGE) expression through the downstream signaling pathway to facilitate AGE–RAGE interaction. In this regulation process, the primary signaling pathways are NF-κB and STAT3. However, the inhibition of these transcription factors cannot completely block the upregulation of RAGE, which indicates AGEs may also impact RAGE expression via other pathways. In this study, we revealed that AGEs can exhibit epigenetic impacts on RAGE expression. Here, we used carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) to treat liver cells and discovered that AGEs can promote the demethylation of the RAGE promoter region. To verify this epigenetic modification, we employed dCAS9-DNMT3a with sgRNA to specifically modify the RAGE promoter region against the effect of carboxymethyl-lysine and carboxyethyl-lysine. The elevated RAGE expressions were partially repressed after AGE-induced hypomethylation statuses were reversed. Additionally, TET1 were also upregulated in AGE-treated cells, indicating AGEs may epigenetically modulate RAGE through the elevating TET1 level.
- 14 February 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1062229
Open AccessAdvanced glycation end products regulate the receptor of AGEs epigenetically
Advanced glycation end-products (AGEs) can boost their receptor of AGE (RAGE) expression through the downstream signaling pathway to facilitate AGE–RAGE interaction. In this regulation process, the primary signaling pathways are NF-κB and STAT3. However, the inhibition of these transcription factors cannot completely block the upregulation of RAGE, which indicates AGEs may also impact RAGE expression via other pathways. In this study, we revealed that AGEs can exhibit epigenetic impacts on RAGE expression. Here, we used carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) to treat liver cells and discovered that AGEs can promote the demethylation of the RAGE promoter region. To verify this epigenetic modification, we employed dCAS9-DNMT3a with sgRNA to specifically modify the RAGE promoter region against the effect of carboxymethyl-lysine and carboxyethyl-lysine. The elevated RAGE expressions were partially repressed after AGE-induced hypomethylation statuses were reversed. Additionally, TET1 were also upregulated in AGE-treated cells, indicating AGEs may epigenetically modulate RAGE through the elevating TET1 level.
- Open Access
- 17 November 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 1028575
Intra-articular injection of clioquinol ameliorates osteoarthritis in a rabbit model
Osteoarthritis (OA) is characterized by the degeneration of articular cartilage. Decreased autophagy is tightly associated with chondrocyte death, which contributes to the progression of OA. Thus, pharmacological activation of autophagy may be a promising therapeutic approach for OA. Here, we discovered that clioquinol, an antibiotic, significantly induces autophagy in OA chondrocytes from human tissue and rabbit model. Meanwhile, clioquinol can also augment the expression of extracellular matrix (ECM) components and suppress inflammatory mediators to improve OA microenvironment. Intra-articular injection of clioquinol can greatly prevent or slow down the development of this disease in a trauma-induced rabbit model of osteoarthritis. Such protective effect induced by clioquinol was at least in part explained by decreasing chondrocyte apoptosis and increasing autophagy. This study reveals the therapeutic potential of clioquinol in OA treatment.
- 17 November 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 1028575
Open AccessIntra-articular injection of clioquinol ameliorates osteoarthritis in a rabbit model
Osteoarthritis (OA) is characterized by the degeneration of articular cartilage. Decreased autophagy is tightly associated with chondrocyte death, which contributes to the progression of OA. Thus, pharmacological activation of autophagy may be a promising therapeutic approach for OA. Here, we discovered that clioquinol, an antibiotic, significantly induces autophagy in OA chondrocytes from human tissue and rabbit model. Meanwhile, clioquinol can also augment the expression of extracellular matrix (ECM) components and suppress inflammatory mediators to improve OA microenvironment. Intra-articular injection of clioquinol can greatly prevent or slow down the development of this disease in a trauma-induced rabbit model of osteoarthritis. Such protective effect induced by clioquinol was at least in part explained by decreasing chondrocyte apoptosis and increasing autophagy. This study reveals the therapeutic potential of clioquinol in OA treatment.
- 1 November 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 154, 275-289
Bioprinted living tissue constructs with layer-specific, growth factor-loaded microspheres for improved enthesis healing of a rotator cuff
- 1 November 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 154, 275-289
Bioprinted living tissue constructs with layer-specific, growth factor-loaded microspheres for improved enthesis healing of a rotator cuff
- Top Cited PapersOpen Access
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (12) , 5911-5925
Synergistic enhancement of tendon-to-bone healing via anti-inflammatory and pro-differentiation effects caused by sustained release of Mg2+/curcumin from injectable self-healing hydrogels
Poor healing response after rotator cuff reconstruction is multifactorial, with the inflammatory microenvironment and deficiency of stem cell differentiation factors at the lesion site being most relevant. However, there is a lack of effective tissue engineering strategies that can simultaneously exert anti-inflammatory and pro-differentiation effects to promote rotator cuff healing.
- 1 January 2021
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (12) , 5911-5925
Top Cited PapersOpen AccessSynergistic enhancement of tendon-to-bone healing via anti-inflammatory and pro-differentiation effects caused by sustained release of Mg2+/curcumin from injectable self-healing hydrogels
Poor healing response after rotator cuff reconstruction is multifactorial, with the inflammatory microenvironment and deficiency of stem cell differentiation factors at the lesion site being most relevant. However, there is a lack of effective tissue engineering strategies that can simultaneously exert anti-inflammatory and pro-differentiation effects to promote rotator cuff healing.